InvestorsHub Logo
Followers 84
Posts 1928
Boards Moderated 0
Alias Born 03/05/2014

Re: EponymousKook post# 82924

Sunday, 06/07/2020 10:00:11 AM

Sunday, June 07, 2020 10:00:11 AM

Post# of 232965
Your articulation of the Covid CD-10 and CD-12 trials is what I have believed to be the case also. Thank you for connecting the dots so clearly.

I have stayed all in because of this scenario. It is why Nader is not pushing for a big raise prior to the unblinding and read out of the data. I’m sure NP, JL, and BP have discussed the blood work daily since the trials began. They have been telegraphing the results on video with their posture at an increasing level as of late. BP has not been on as much recently because he has to be very careful not to appear too overly confident on a blinded trial.

The CD-12 trial for severe is the knock out punch because this is where there is no other drug saving lives like Leronlimab once Covid progresses to the respiratory.

IMHO the likelihood of this all falling into place is very high and then it will be up to the FDA to step up and grant emergency approval. They can’t question safety which is their number one reason for demanding another trial with more patients. In addition the manufacturing card is in place with multiple contractors.

A government grant would seem to be a slam dunk with what has been given away for much less promising drugs. If not we should definitely have Big Pharma’s full attention and our financial options will be much more advantageous.

As I have said if the read out is anything but stellar I will be shocked given all of the information.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News